[HTML][HTML] Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target
M Zhao, Z Zheng, Z Yin, J Zhang, J Qin, J Wan… - Pharmacological …, 2023 - Elsevier
Accumulating evidence suggests that inflammation plays an important role in the
pathophysiology of the initiation and progression of cardiovascular and metabolic diseases …
pathophysiology of the initiation and progression of cardiovascular and metabolic diseases …
Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target
M Zhao, Z Zheng, Z Yin, J Zhang… - Pharmacological …, 2023 - pubmed.ncbi.nlm.nih.gov
Accumulating evidence suggests that inflammation plays an important role in the
pathophysiology of the initiation and progression of cardiovascular and metabolic diseases …
pathophysiology of the initiation and progression of cardiovascular and metabolic diseases …
[PDF][PDF] Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target
M Zhao, Z Zheng, Z Yin, J Zhang, J Qin, J Wan… - researchgate.net
Accumulating evidence suggests that inflammation plays an important role in the
pathophysiology of the initiation and progression of cardiovascular and metabolic diseases …
pathophysiology of the initiation and progression of cardiovascular and metabolic diseases …
[PDF][PDF] Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target
M Zhao, Z Zheng, Z Yin, J Zhang, J Qin, J Wan… - researchgate.net
Accumulating evidence suggests that inflammation plays an important role in the
pathophysiology of the initiation and progression of cardiovascular and metabolic diseases …
pathophysiology of the initiation and progression of cardiovascular and metabolic diseases …